Leo Pharma gets green light from FDA for Adbry autoinjector
Leo Pharma has received FDA approval for a new 300 mg. single-dose autoinjector for Adbry for the treatment of moderate to severe atopic dermatitis in patients 12 years and older.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.